Motexafin lutetium-photodynamic therapy of prostate cancer: Short and long term effects on PSA

Ítems similars

• Interstitial Fluorescence Spectroscopy in the Human Prostate During Motexafin Lutetium–Mediated Photodynamic Therapy
  per: Finlay, Jarod C., et al.
  Publicat: (2006)
• Optical Properties of Human Prostate at 732 nm Measured In Vivo During Motexafin Lutetium–mediated Photodynamic Therapy()
  per: Zhu, Timothy C., et al.
  Publicat: (2005)
• Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy
  per: Zhu, Timothy C., et al.
  Publicat: (2004)
• Increasing Damage to Tumor Blood Vessels during Motexafin Lutetium-PDT through Use of Low Fluence Rate
  per: Busch, Theresa M., et al.
  Publicat: (2010)
• In vivo measurement of fluorescence emission in the human prostate during photodynamic therapy
  per: Finlay, Jarod C., et al.
  Publicat: (2005)